Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Return on Equity (2016 - 2025)

Medifast (MED) has disclosed Return on Equity for 15 consecutive years, with 0.09% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity fell 10.0% year-over-year to 0.09%, compared with a TTM value of 0.09% through Dec 2025, down 10.0%, and an annual FY2025 reading of 0.09%, down 10.0% over the prior year.
  • Return on Equity was 0.09% for Q4 2025 at Medifast, down from 0.0% in the prior quarter.
  • Across five years, Return on Equity topped out at 1.08% in Q3 2022 and bottomed at 0.09% in Q4 2025.
  • Average Return on Equity over 5 years is 0.52%, with a median of 0.69% recorded in 2023.
  • The sharpest move saw Return on Equity grew 22bps in 2022, then crashed -60bps in 2024.
  • Year by year, Return on Equity stood at 0.82% in 2021, then grew by 14bps to 0.94% in 2022, then tumbled by -46bps to 0.5% in 2023, then plummeted by -98bps to 0.01% in 2024, then plummeted by -994bps to 0.09% in 2025.
  • Business Quant data shows Return on Equity for MED at 0.09% in Q4 2025, 0.0% in Q3 2025, and 0.02% in Q2 2025.